News

CAT-2054 is an oral small molecule that modulates the SREBP pathway. SREBP is a master regulator of lipid metabolism that impacts LDL, triglycerides and glucose with the potential

DMD is a rare form of muscular dystrophy that leads to progressive and debilitating weakening of muscles in young males. It occurs due to mutations in the gene

ALLN-177 is designed to treat secondary hyperoxaluria in patients with a history of calcium oxalate kidney stones. Partner Fund Management led the Series C financing round, which included

The first study, Javelin Gastric 100, will compare the switch from first-line chemotherapy to maintenance therapy with avelumab versus continuation of chemotherapy. It will evaluate the potential superiority

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) has approved Dengvaxia, tetravalent dengue vaccine, for the prevention of disease caused by all four dengue virus serotypes

STARTRK-NG (which stands for "Studies of Tumor Alterations Responsive to Targeting Receptor Kinases – Next Generation") is a multicenter, open label, dose-escalation and expansion study designed to determine

The Company plans to use the proceeds from the financing to advance its pipeline of direct tumor targeting and immuno-stimulatory epigenetic inhibitors, which includes its two wholly-owned, clinical-stage

The agreement creates opportunities for scientists at Princeton University and Bristol-Myers Squibb to collaborate on top-flight synthetic chemistry research, leveraging the two sites’ close proximity to foster a

Celldex previously announced the collaboration with Roche to evaluate the novel immunotherapy combination in March 2015. Under the terms of the agreement, Roche will provide atezolizumab, and Celldex